In this study, we analyzed the activation of bone-marrow derived dendritic cells (BMDCs) from mice lacking the cd14-gene with purified Legionella pneumophila lipopolysaccharide and with viable or formalin-killed L. pneumophila .We found that low concentrations of LPS and doses of L. pneumophila that are relevant to infection are dependent on CD14 to activate BMDCs. Higher concentrations of LPS are able to overcome the lack of CD14 indicating that other receptors are involved. We, therefore, included studies using BMDCs from mice lacking functional TLR2 and/or TLR4 molecules. We found that purified L. pneumophila LPS as well as L. pneumophila either viable or formalin-killed are able to activate BMDCs from TLR4-deficient C3H/HeJ mice but fail to activate BMDCs from TLR2-knockout mice. Our data show that not only purified LPS from L. pneumophila but also the microorganism itself stimulate BMDCs via TLR2 and that this stimulation is dependent on CD14 in this mouse model.
Ciesielski CA , Blaser MJ, Wang WLSerogroup specificity of Legionella pneumophila is related to lipopolysaccharide characteristics. Infect Immun1986; 51: 397—404.
2.
Conlan JW, Ashworth LAThe relationship between the serogroup antigen and lipopolysaccharide of Legionella pneumophila. J Hygiene (Lond) 1986; 96: 39—48.
3.
Weeratna R., Stamler DA, Edelstein PH et al. Human and guinea pig immune responses to Legionella pneumophila protein antigens OmpS and Hsp60. Infect Immun1994; 62: 3454—3462.
4.
Horwitz MA, Silverstein SCInteraction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med1981; 153: 386—397.
Friedman H., Widen R., Klein T., Johnson W.Immunostimulation by Legionella pneumophila antigen preparations in vivo and in vitro. Infect Immun1984; 43: 347—352.
9.
Friedman H., Widen R., Klein T., Searls L., Cabrian K.Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro . Infect Immun1984; 43: 314—319.
10.
Neild AL, Roy CRLegionella reveal dendritic cell functions that facilitate selection of antigens for MHC class II presentation. Immunity2003 ; 18: 813—823.
11.
Antal-Szalmas P.Evaluation of CD14 in host defence. Eur J Clin Invest2000; 30: 167—179.
12.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JCCD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990; 249: 1431—1433.
13.
Golenbock DT , Liu Y., Millham FH, Freeman MW, Zoeller RASurface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J Biol Chem1993; 268: 22055—22059.
14.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
15.
Shimazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med1999; 189: 1777—1782.
16.
Ulevitch RJ , Tobias PSRecognition of endotoxin by cells leading to transmembrane signaling. Curr Opin Immunol1994; 6: 125—130.
17.
Girard R., Pedron T., Uematsu S. et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci2003; 116: 293—302.
18.
Zähringer U. , Knirel YA, Lindner B. et al. The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res1995; 392: 113—139.
19.
Helbig JH, Luck PC, Knirel YA, Witzleb W., Zähringer U.Molecular characterization of a virulence-associated epitope on the lipopolysaccharide of Legionella pneumophila serogroup 1. Epidemiol Infect1995; 115: 71—78.
20.
Neumeister B., Faigle M., Sommer M. et al. Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14. Infect Immun1998; 66: 4151—4157.
21.
Vabulas RM, Braedel S., Hilf N. et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem2002; 277: 20847—20853.
22.
Yoshimura A., Lien E., Ingalls RR, Tuomanen E., Dziarski R., Golenbock D.Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol1999; 163: 1—5.
23.
Flo TH, Halaas O., Lien E. et al. HumanToll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol2000; 164: 2064—2069.
24.
Hirschfeld M. , Weis JJ, Toshchakov V. et al .Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun2001; 69: 1477—1482.
25.
Werts C., Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol2001; 2: 346—352.
26.
Lettinga KD , Florquin S., Speelman P., van Ketel R., van der, PT, Verbon A.Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model . J Infect Dis2002; 186: 570—573.
Netea MG, Kullberg BJ, Galama JM, Stalenhoef AF, Dinarello CA, Van der Meer JWNon-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol2002; 32: 1188—1195.
29.
Bazil V., Horejsi V., Baudys M. et al. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol1986 ; 16: 1583—1589.
30.
Husmann LK, Johnson W.Cytotoxicity of extracellular Legionella pneumophila. Infect Immun1994; 62: 2111—2114.
31.
Henneke P., Takeuchi O., Malley R. et al. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol2002; 169: 3970—3977.
32.
Kikuchi T., Kobayashi T., Gomi K. et al. Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses. J Immunol2004; 172: 1727—1734.
